X-Linked G6PD Deficiency Protects Hemizygous Males but Not Heterozygous Females against Severe Malaria
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Glucose-6-phosphate dehydrogenase (G6PD) is important in the control of oxidant stress in erythrocytes, the host cells for Plasmodium falciparum. Mutations in this enzyme produce X-linked deficiency states associated with protection against malaria, notably in Africa where the A- form of G6PD deficiency is widespread. Some reports have proposed that heterozygous females with mosaic populations of normal and deficient erythrocytes (due to random X chromosome inactivation) have malaria resistance similar to or greater than hemizygous males with populations of uniformly deficient erythrocytes. These proposals are paradoxical, and they are not consistent with currently hypothesized mechanisms of protection. METHODS AND FINDINGS: We conducted large case-control studies of the A- form of G6PD deficiency in cases of severe or uncomplicated malaria among two ethnic populations of rural Mali, West Africa, where malaria is hyperendemic. Our results indicate that the uniform state of G6PD deficiency in hemizygous male children conferred significant protection against severe, life-threatening malaria, and that it may have likewise protected homozygous female children. No such protection was evident from the mosaic state of G6PD deficiency in heterozygous females. We also found no significant differences in the parasite densities of males and females with differences in G6PD status. Pooled odds ratios from meta-analysis of our data and data from a previous study confirmed highly significant protection against severe malaria in hemizygous males but not in heterozygous females. Among the different forms of severe malaria, protection was principally evident against cerebral malaria, the most frequent form of life-threatening malaria in these studies. CONCLUSIONS: The A- form of G6PD deficiency in Africa is under strong natural selection from the preferential protection it provides to hemizygous males against life-threatening malaria. Little or no such protection is present among heterozygous females. Although these conclusions are consistent with data from at least one previous study, they have not heretofore been realized to our knowledge, and they therefore give fresh perspectives on malaria protection by G6PD deficiency as an X-linked trait.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In a similar fashion, hemizygous males and healthy heterozygous females carrying a mutation in the G6PD (for glucose-6-phasphate dehydrogenase) gene are protected from severe malaria (Guindo et al., 2007).”
From Iron in infection and immunity (2020) · cites this paper as Guindo et al., 2007
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“It is likely that a similar mechanism underlies the protective effect exerted by other chronic hemolytic conditions against malaria, including hemoglobin C [229,230], glucose 6 phosphate dihydrogenase (G6PD) deficiency in males [231], bor a-thalassemia [230] as well as mutations involved in RBC cytoskeleton or membrane protein defects [232].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [231]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Common West African HLA antigens are associated with protection from severe malaria
Hill, A. V. S., Allsopp, C. E. M., Kwiatkowski, D., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J., & Greenwood, B. M. (1991) · Nature · doi:10.1038/352595a0 · Cited by 1,552 · cited 6×
“Mutant hemoglobins also contribute to protection against severe malaria in West Africa [13,18,19].”
BackgroundResultInfluentialSatpathy, S. K., Mohanty, N., Nanda, P., & Samal, G. (2004) · The Indian Journal of Pediatrics · doi:10.1007/bf02723094 · Cited by 1,130
Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.
(2000) · PubMed · Cited by 1,069
Protective effects of the sickle cell gene against malaria morbidity and mortality
Aidoo, M., Terlouw, D. J., Kolczak, M. S., McElroy, P. D., ter Kuile, F. O., Kariuki, S., Nahlen, B. L., Lal, A. A., & Udhayakumar, V. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08273-9 · Cited by 700 · cited 1×
“much-reduced morbidity and mortality rates in children after the first few years of life [16,17].”
BackgroundTishkoff, S. A., Varkonyi, R., Cahinhinan, N., Abbes, S., Argyropoulos, G., Destro-Bisol, G., Drousiotou, A., Dangerfield, B., Lefranc, G., Loiselet, J., et al. (2001) · Science · doi:10.1126/science.1061573 · Cited by 630 · cited 1×
“*A− allele arose within the past 3,840–11,760 years and spread with agriculture and malaria in Africa [”
BackgroundRuwende, C., Khoo, S. C., Snow, R. W., Yates, S. N. R., Kwiatkowski, D., Gupta, S., Warn, P., Allsopp, C. E. M., Gilbert, S. C., Peschu, N., et al. (1995) · Nature · doi:10.1038/376246a0 · Cited by 595 · cited 8×
“[5] for evidence of protection against two leading forms of severe malaria highly fatal to African children, cerebral malaria and severe anemia.”
BackgroundMethodResultInfluentialHaemoglobin C protects against clinical Plasmodium falciparum malaria
Modiano, D., Luoni, G., Sirima, B. S., Simporé, J., Verra, F., Konaté, A., Rastrelli, E., Olivieri, A., Calissano, C., Paganotti, G. M., et al. (2001) · Nature · doi:10.1038/35104556 · Cited by 381
Cappadoro, M., Giribaldi, G., O'Brien, E., Turrini, F., Mannu, F., Ulliers, D., Simula, G., Luzzatto, L., & Arese, P. (1998) · Blood · doi:10.1182/blood.v92.7.2527 · Cited by 339
The burden of malaria mortality among African children in the year 2000
Rowe, A. K., Rowe, S. Y., Snow, R. W., Korenromp, E. L., Schellenberg, J. R. A., Stein, C., Nahlen, B. L., Bryce, J., Black, R. E., & Steketee, R. W. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl027 · Cited by 302 · cited 1×
“In rural villages of West Africa where malaria is hyperendemic and adequate medication can be difficult to obtain, virtually all children experience malaria episodes early in life, and approximately 20% die from the disease by age five [12].”
BackgroundMetabolic polymorphisms and the role of infectious diseases in human evolution.
Motulsky, A. G. (1960) · PubMed · Cited by 277
Cited by
Schneider, D. S., & Ayres, J. S. (2008) · Nature Reviews Immunology · doi:10.1038/nri2432 · Cited by 783
Phillips, M. A., Burrows, J. N., Manyando, C., van Huijsduijnen, R. H., Van Voorhis, W. C., & Wells, T. N. C. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.50 · Cited by 649
Howes, R. E., Piel, F. B., Patil, A. P., Nyangiri, O. A., Gething, P. W., Dewi, M., Hogg, M. M., Battle, K. E., Padilla, C. D., Baird, J. K., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001339 · Cited by 562
“falciparum malaria [58,59], and an Figure 4.”
Glucose-6-Phosphate Dehydrogenase Deficiency
Luzzatto, L., Nannelli, C., & Notaro, R. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.11.006 · Cited by 400
Genome-wide and fine-resolution association analysis of malaria in West Africa
Jallow, M., Teo, Y. Y., Small, K. S., Rockett, K. A., Deloukas, P., Clark, T. G., Kivinen, K., Bojang, K. A., Conway, D. J., Pinder, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.388 · Cited by 374
“We might have expected associations at G6PD and HBA1-HBA2 , the loci for glucose-6-phosphate deficienc”
Self-citationIron in infection and immunity
Nairz, M., & Weiss, G. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100864 · Cited by 359
Sickle Hemoglobin Confers Tolerance to Plasmodium Infection
Ferreira, A., Marguti, I., Bechmann, I., Jeney, V., Chora, Â., Palha, N. R., Rebelo, S., Henri, A., Beuzard, Y., & Soares, M. P. (2011) · Cell · doi:10.1016/j.cell.2011.03.049 · Cited by 340
G6PD deficiency: the genotype-phenotype association
Mason, P. J., Bautista, J. M., & Gilsanz, F. (2007) · Blood Reviews · doi:10.1016/j.blre.2007.05.002 · Cited by 305
Population genetics of malaria resistance in humans
Hedrick, P. W. (2011) · Heredity · doi:10.1038/hdy.2011.16 · Cited by 297
Hammad, M., Raftari, M., Cesário, R., Salma, R., Godoy, P., Emami, S. N., & Haghdoost, S. (2023) · Antioxidants · doi:10.3390/antiox12071371 · Cited by 231
The Iron age of host–microbe interactions
Soares, M. P., & Weiss, G. (2015) · The EMBO Reports · doi:10.15252/embr.201540558 · Cited by 227
“It is likely that a similar mechanism underlies the protective effect exerted by other chronic hemolytic conditions against malaria, including hemoglobin C [229,230], glucose 6 phosphate dihydrogenase (G6PD) deficiency in males [231], b- or a-thalassemia [230] as well as mutations involved in RBC cytoskeleton or membr…”
Howes, R. E., Battle, K. E., Satyagraha, A. W., Baird, J. K., & Hay, S. I. (2013) · Advances in Parasitology · doi:10.1016/b978-0-12-407826-0.00004-7 · Cited by 220
“case-control study in most respects was subsequently conducted in Malian children (Guindo et al., 2007), except that the control samples used were of uncomplicated malaria cases, rather than asymptomatic/malaria-free cases, a reflection of the local hyperendemic malaria transmission.”
ResultGlucose-6-Phosphate Dehydrogenase Deficiency and Antimalarial Drug Development
Beutler, E., Duparc, S., & _, _. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.779 · Cited by 215
“Table 1 summarizes the main deficient variants found in different regions, although information on the molecular epidemiology of G6PD deficiency is patchy globally.20–37 In Africa, the prevalence of G6PD deficiency has been reported as high as 28.1% in southwest Nigeria,22 22.5% in Congo (Brazzaville),38 15.7% in Mali…”
BackgroundInfluentialAntagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease alleles
Carter, A. J., & Nguyen, A. Q. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-160 · Cited by 172
Positively Selected G6PD -Mahidol Mutation Reduces Plasmodium vivax Density in Southeast Asians
Louicharoen, C., Patin, E., Paul, R., Nuchprayoon, I., Witoonpanich, B., Peerapittayamongkol, C., Casademont, I., Sura, T., Laird, N. M., Singhasivanon, P., et al. (2009) · Science · doi:10.1126/science.1178849 · Cited by 171
Mechanisms of genetically-based resistance to malaria
López, C., Saravia, C., Gomez, A., Hoebeke, J., & Patarroyo, M. A. (2010) · Gene · doi:10.1016/j.gene.2010.07.008 · Cited by 166
“males and homozygous females) but not in its mosaic state (heterozygous females) (Guindo et al., 2007).”
BackgroundPrimaquine in vivax malaria: an update and review on management issues
Fernando, D., Rodrigo, C., & Rajapakse, S. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-351 · Cited by 160
“This phenomenon has been demonstrated for the African A variant, showing that it confers protection against lethal falciparum malaria [33,34].”
BackgroundLacerda, M. V., Mourão, M. P., Alexandre, M. A., Siqueira, A. M., Magalhães, B. M., Martinez-Espinosa, F. E., Santana Filho, F. S., Brasil, P., Ventura, A. M., Tada, M. S., et al. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-12 · Cited by 158
“Male hemizygotes for this deficiency also showed to be protected against severe falciparum malaria [151].”
BackgroundGenetic polymorphisms linked to susceptibility to malaria
Driss, A., Hibbert, J. M., Wilson, N. O., Iqbal, S. A., Adamkiewicz, T. V., & Stiles, J. K. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-271 · Cited by 179
“The group genotyped the SNP rs1050828, a G6PD coding polymorphism, that was suggested to be a marker for protection against SM [25].”
BackgroundPeters, A. L., & Noorden, C. J. F. V. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.953828 · Cited by 185
“According to Guindo et al. (2007), heterozygous females suffer from the same morbidity and mortality of Plasmodium falciparum infection as do non-deficient patients.”
BackgroundFactors Determining the Heterogeneity of Malaria Incidence in Children in Kampala, Uganda
Clark, T. D., Greenhouse, B., Njama‐Meya, D., Nzarubara, B., Maiteki‐Sebuguzi, C., Staedke, S. G., Seto, E., Kamya, M. R., Rosenthal, P. J., & Dorsey, G. (2008) · The Journal of Infectious Diseases · doi:10.1086/589778 · Cited by 139
“against severe malaria in males but not females [31].”
Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility
Clark, T. G., Fry, A. E., Auburn, S., Campino, S., Diakite, M., Green, A., Richardson, A., Teo, Y. Y., Small, K., Wilson, J., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.8 · Cited by 133
Pamba, A., Richardson, N. D., Carter, N., Duparc, S., Premji, Z., Tiono, A. B., & Luzzatto, L. (2012) · Blood · doi:10.1182/blood-2012-03-416032 · Cited by 104
Host erythrocyte polymorphisms and exposure to Plasmodium falciparum in Papua New Guinea
Fowkes, F. J., Michon, P., Pilling, L., Ripley, R. M., Tavul, L., Imrie, H. J., Woods, C. M., Mgone, C. S., Luty, A. J., & Day, K. P. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-1 · Cited by 126
“Case-control studies have demonstrated that these polymorphisms reduce the risk of severe falciparum malaria rather than mild malaria [1-22].”
Mbanefo, E. C., Ahmed, A. M., Titouna, A., Elmaraezy, A., Trang, N. T. H., Long, N. P., Anh, N. H., Nghi, T. D., Hung, B. T., Hieu, M. V., et al. (2017) · Scientific Reports · doi:10.1038/srep45963 · Cited by 130
Crompton, P. D., Traore, B., Kayentao, K., Doumbo, S., Ongoiba, A., Diakite, S. A. S., Krause, M. A., Doumtabe, D., Kone, Y., Weiss, G., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/592224 · Cited by 121
“The mutation responsible for G6PD deficiency in Mali (G6PD*A ) was identified by restriction-fragment length polymorphism analysis of PCR-amplified DNA samples, as described elsewhere [10].”
Self-citationUyoga, S. M., Ndila, C., Macharia, A., Nyutu, G., Shah, S. S., Peshu, N., Clarke, G. M., Kwiatkowski, D. P., Rockett, K. A., & Williams, T. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00152-0 · Cited by 116
The Pentose Phosphate Pathway Dynamics in Cancer and Its Dependency on Intracellular pH
Alfarouk, K. O., Ahmed, S. B. M., Elliott, R. L., Benoit, A., Alqahtani, S. S., Ibrahim, M. E., Bashir, A. H. H., Alhoufie, S. T. S., Elhassan, G. O., Wales, C. C., et al. (2020) · Metabolites · doi:10.3390/metabo10070285 · Cited by 116
“Interestingly, G6PDH deficiency is an X-linked recessive hereditary disease [24,25]; this deficiency is accompanied by several clinical manifestations, as follows:”
BackgroundAntagonistic Pleiotropy in Human Disease
Byars, S., & Voskarides, K. (2019) · Journal of Molecular Evolution · doi:10.1007/s00239-019-09923-2 · Cited by 106
Red Blood Cell Polymorphism and Susceptibility to Plasmodium vivax
Zimmerman, P. A., Ferreira, M. U., Howes, R. E., & Mercereau‐Puijalon, O. (2013) · Advances in Parasitology/Advances in parasitology · doi:10.1016/b978-0-12-407826-0.00002-3 · Cited by 122
Sirugo, G., Hennig, B. J., Adeyemo, A., Matimba, A., Newport, M. J., Ibrahim, M. E., Ryckman, K. K., Tacconelli, A., Mariani‐Costantini, R., Novelli, G., et al. (2008) · Human Genetics · doi:10.1007/s00439-008-0511-y · Cited by 105
Clarke, G. M., Rockett, K. A., Kivinen, K., Hubbart, C., Jeffreys, A. E., Rowlands, K., Jallow, M., Conway, D. J., Bojang, K., Pinder, M., et al. (2017) · eLife · doi:10.7554/elife.15085 · Cited by 101
“, 2016) or that it is confined to hemizygous G6PD-deficient males (Guindo et al., 2007), or that there are no protective effects at all (Johnson et al.”
BackgroundSelf-citationLeslie, T., Briceño, M., Mayan, I., Mohammed, N., Klinkenberg, E., Sibley, C. H., Whitty, C. J. M., & Rowland, M. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000283 · Cited by 91
“This hypothesis was confirmed in endemic areas of Africa where the African (A2) variant of G6PD deficiency protected against severe disease [10–12].”
BackgroundInfluentialLo, K. S., Wilson, J. G., Lange, L. A., Folsom, A. R., Galarneau, G., Ganesh, S. K., Grant, S. F. A., Keating, B. J., McCarroll, S. A., Mohler, E. R., et al. (2010) · Human Genetics · doi:10.1007/s00439-010-0925-1 · Cited by 98
“…that the canonical glucose-6 phosphate dehydrogenase (G6PD) A-allele (rs1050828) implicated in G6PD deficiency (MIM #305900) and malaria resistance (Guindo et al. 2007; Ruwende et al. 1995; Tishkoff et al. 2001) also associates with RBC, Hct, Hb, and MCV variation (P < 2 × 10−13) in African…”
Carter, N., Pamba, A., Duparc, S., & Waitumbi, J. N. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-241 · Cited by 65
G6PD deficiency in Latin America: systematic review on prevalence and variants
Monteiro, W. M., Val, F., Siqueira, A. M., Franca, G. P., Sampaio, V. D. S., de Melo, G. C., Almeida, A. C., Brito, M. A. M., Peixoto, H. M., Fuller, D. O., et al. (2014) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-0276140123 · Cited by 110
“G6PDd is also thought to be a protection factor against severe manifestations of malaria, although studies regarding which individuals, hemizygous males or heterozygous females, may be protected present discrepancies (Ruwende et al. 1995, Guindo et al. 2007).”
BackgroundPhompradit, P., Kuesap, J., Chai่jaroenkul, W., Rueangweerayut, R., Hongkaew, Y., Yamnuan, R., & Na‐Bangchang, K. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-368 · Cited by 96
“falciparum malaria among nonimmune adults [30-32].”
Manjurano, A., Sepulveda, N., Nadjm, B., Mtove, G., Wangai, H., Maxwell, C., Olomi, R., Reyburn, H., Riley, E. M., Drakeley, C. J., et al. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1004960 · Cited by 65
“However, even in large well-powered studies, associations between 202A/376G G6PD and protection from severe disease have been inconsistent, revealing protective effects in female heterozygotes [8, 11,17,18,19], in male hemizygotes [12,13], in both [14], or no protection [15].”
BackgroundEffect of red blood cell variants on childhood malaria in Mali: a prospective cohort study
Lopera-Mesa, T. M., Doumbia, S., Konate, D. S., Anderson, J. M., Doumbouya, M., Keita, A. S., Diakité, S. A. S., Traoré, K., Krause, M., Diouf, A., et al. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00043-5 · Cited by 83
Self-citationVerra, F., Mangano, V. D., & Modiano, D. (2009) · Parasite Immunology · doi:10.1111/j.1365-3024.2009.01106.x · Cited by 96
The impact of malaria parasitism: from corpuscles to communities
Wellems, T. E., Hayton, K., & Fairhurst, R. M. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38307 · Cited by 90
Self-citationLopera-Mesa, T. M., Doumbia, S., Chiang, S., Zeituni, A. E., Konate, D. S., Doumbouya, M., Keita, A. S., Stepniewska, K., Traoré, K., Diakité, S. A. S., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit082 · Cited by 78
“and G6PD deficiency genotypes, as described [27, 28].”
Self-citationDolo, H., Coulibaly, Y. I., Dembele, B., Konate, S., Coulibaly, S. Y., Doumbia, S. S., Diallo, A. A., Soumaoro, L., Coulibaly, M. E., Diakite, S. A. S., et al. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001890 · Cited by 66
“Glucose-6-phosphate dehydrogenase (G6PD) deficiency was assessed by restriction enzyme analysis [18] in all 62 subjects.”
MethodSelf-citationGenetic Determination and Linkage Mapping of Plasmodium falciparum Malaria Related Traits in Senegal
Sakuntabhai, A., Ndiaye, R., Casadémont, I., Peerapittayamonkol, C., Rogier, C., Tortevoye, P., Tall, A., Paul, R. E. L., Turbpaiboon, C., Phimpraphi, W., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002000 · Cited by 78
Johnson, M. K., Clark, T. D., Njama‐Meya, D., Rosenthal, P. J., & Parikh, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007246 · Cited by 74
“. Since that initial observation, dozens of clinical association studies have been performed, yielding varied results. Selected studies of severe disease showed a decrease in the risk of severe malaria in hemizygous males”
ResultPharmGKB summary: very important pharmacogene information for G6PD
McDonagh, E. M., Thorn, C. F., Bautista, J. M., Youngster, I., Altman, R. B., & Klein, T. E. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834eb313 · Cited by 88
“falciparum parasitaemia [110,111], and yet other studies find no protection from severe malaria [109].”
Backgroundα-Thalassemia Impairs the Cytoadherence of Plasmodium falciparum-Infected Erythrocytes
Krause, M. A., Diakite, S. A. S., Lopera-Mesa, T. M., Amaratunga, C., Arie, T., Traore, K., Doumbia, S., Konate, D., Keefer, J. R., Diakite, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037214 · Cited by 63
“The presence of the G6PD*A2 allele was determined as described [19].”
MethodSelf-citationCandidate Polymorphisms and Severe Malaria in a Malian Population
Touré, O., Konaté, S., Sissoko, S., Niangaly, A., Barry, A., Sall, A. H., Diarra, E., Poudiougou, B., Sepúlveda, N., Campino, S. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043987 · Cited by 63
Self-citationMonteiro, W. M., Franca, G. P., de Melo, G. C., Queiroz, A. L., Brito, M. A. M., Peixoto, H. M., de Oliveira, M. R. F., Romero, G. A. S., Bassat, Q., & Lacerda, M. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-70 · Cited by 73
“This phenomenon has been investigated mainly for the African variant, which has been shown to confer protection against lethal falciparum malaria [4].”
BackgroundGoheen, M. M., Campino, S. G., & Cerami, C. (2017) · British Journal of Haematology · doi:10.1111/bjh.14886 · Cited by 71
“…They suggest that heterozygote females are the only ones protected against severe malaria (Malaria Genomic Epidemiology Network, 2014; Sirugo et al, 2014; Uyoga et al, 2015) or that hemizygote males and homozygote females are the only ones protected against severe malaria (Guindo et al, 2007).”
BackgroundShah, S. S., Diakite, S. A. S., Traore, K., Diakite, M., Kwiatkowski, D. P., Rockett, K. A., Wellems, T. E., & Fairhurst, R. M. (2012) · Scientific Reports · doi:10.1038/srep00299 · Cited by 49
“Genotyping Genotyping of the G6PD 202 polymorphism was performed by restriction fragment length polymorphism (RFLP) analysis using a nested PCR protocol, as described previousl”
MethodSelf-citationPasaribu, A. P., Chokejindachai, W., Sirivichayakul, C., Tanomsing, N., Chavez, I., Tjitra, E., Pasaribu, S., Imwong, M., White, N. J., & Dondorp, A. M. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit407 · Cited by 56
Li, Q., Yang, F., Liu, R., Luo, L., Yang, Y., Zhang, L., Liu, H., Zhang, W., Fan, Z., Yang, Z., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134593 · Cited by 54
Fairhurst, R. M., & Wellems, T. E. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00275-7 · Cited by 74
Self-citationCandidate Human Genetic Polymorphisms and Severe Malaria in a Tanzanian Population
Manjurano, A. M., Clark, T. G., Nadjm, B., Mtove, G. A., Wangai, H., Sepúlveda, N., Campino, S. G., Maxwell, C. A., Olomi, R., Rockett, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047463 · Cited by 54
Sambo, M. R., Trovoada, M. J., Benchimol, C., Quinhentos, V., Gonçalves, L., Velosa, R., Marques, M. I., Sepúlveda, N., Clark, T. G., Mustafa, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011141 · Cited by 50
van Rooij, F. J. A., Qayyum, R., Smith, A. V., Zhou, Y., Trompet, S., Tanaka, T., Keller, M. F., Chang, L.-C., Schmidt, H., Yang, M.-L., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.11.016 · Cited by 55
Irreversible AE1 Tyrosine Phosphorylation Leads to Membrane Vesiculation in G6PD Deficient Red Cells
Pantaleo, A., Ferru, E., Carta, F., Mannu, F., Simula, L. F., Khadjavi, A., Pippia, P., & Turrini, F. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015847 · Cited by 54
Santana, M. S., Monteiro, W. M., Siqueira, A. M., Costa, M. F., Sampaio, V. D. S., Lacerda, M., & Alecrim, M. G. C. (2013) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trt015 · Cited by 55
Shekalaghe, S., Alifrangis, M., Mwanziva, C. E., Enevold, A., Mwakalinga, S., Mkali, H., Kavishe, R. A., Manjurano, A. M., Sauerwein, R. W., DRAKELEY, C. J., et al. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-69 · Cited by 55
“Similar to α+-thalassaemia, G6PD deficiency has been associated with protection against severe [19, 20 ] and mild malaria [18,19,21].”
Awab, G. R., Aaram, F., Jamornthanyawat, N., Suwannasin, K., Pagornrat, W., Watson, J. A., Woodrow, C. J., Dondorp, A. M., Day, N., Imwong, M., et al. (2021) · eLife · doi:10.7554/elife.62448 · Cited by 47
Maiga, B., Dolo, A., Campino, S. G., Sepúlveda, N., Corran, P. H., Rockett, K. A., Troye‐Blomberg, M., Doumbo, O. K., & Clark, T. G. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-270 · Cited by 51
“9%) in severe and uncomplicated malaria cases, respectively, leading to protection against severe disease in hemizygous males but not in heterozygous females [5].”
BackgroundSelf-citationChoudhuri, A., Trompouki, E., Abraham, B. J., Colli, L. M., Kock, K. H., Mallard, W., Yang, M.-L., Vinjamur, D. S., Ghamari, A., Sporrij, A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00738-2 · Cited by 46
Nrf2 as a master regulator of tissue damage control and disease tolerance to infection
Soares, M. P., & Ribeiro, A. M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150054 · Cited by 48
Host genetics and parasitic infections
Mangano, V. D., & Modiano, D. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12793 · Cited by 48
The burden and consequences of inherited blood disorders among young children in western K enya
Suchdev, P. S., Ruth, L. J., Earley, M. C., Macharia, A., & Williams, T. (2012) · Maternal and Child Nutrition · doi:10.1111/j.1740-8709.2012.00454.x · Cited by 49
“Analyses of the effects of G6PD deficiency and malaria were stratified by sex, as malaria protection has only been demonstrated in hemizygous males, not females (Guindo et al. 2007).”
BackgroundMalaria parasites and red cell variants: when a house is not a home
Taylor, S. M., & Fairhurst, R. M. (2014) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000039 · Cited by 48
“and HbS (HbAS or ‘sickle-cell trait’), heterozygosity and homozygosity for HbC (HbAC and HbCC; reviewed in [2]), hemizygosity for glucose-6-phosphate dehydrogenase (G6PD) deficiency [3], and lack of blood group antigens A and B (i.”
BackgroundSelf-citationHemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children
Travassos, M. A., Coulibaly, D. M., Laurens, M. B., Dembélé, A., Tolo, Y., Kone, A. K., Traoré, K., Niangaly, A., Guindo, A., Wu, Y., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv308 · Cited by 37
Self-citationMajor Histocompatibility Complex and Malaria: Focus on Plasmodium vivax Infection
Lima‐Junior, J. D. C., & Pratt-Riccio, L. R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00013 · Cited by 47
Kuwahata, M., Wijesinghe, R., Ho, M., Pelecanos, A. M., Bobogare, A., Landry, L., Bugora, H., Vallely, A. J., & McCarthy, J. S. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-223 · Cited by 46
“However, studies have indicated that this protection may only occurs with certain G6PD variants, and that differing level of protection are likely to be seen in hemizygous males, homozygous and heterozygous females [1,4,6-8].”
BackgroundEnevold, A., Lusingu, J., Mmbando, B. P., Alifrangis, M., Lemnge, M. M., Bygbjerg, I. C., Theander, T. G., & Vestergaard, L. S. (2008) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2008.78.714 · Cited by 43
Nouraie, M. S., Reading, N. S., Campbell, A., Minniti, C. P., RANA, S. R., Luchtman‐Jones, L., Kato, G. J., Gladwin, M. T., Castro, O. L., Prchal, J. T., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08215.x · Cited by 37
“G6PD A) may be associated with episodic haemolysis in individuals of African descent and has a frequency among sickle cell anaemia patients that is similar to the general background population (Bienzle et al, 1975; Las Heras Manso et al, 2008; Segeja et al, 2008).”
BackgroundInfluentialCoexistence of Malaria and Thalassemia in Malaria Endemic Areas of Thailand
Kuesap, J., Chai่jaroenkul, W., Rungsihirunrat, K., Pongjantharasatien, K., & Na‐Bangchang, K. (2015) · Korean Journal of Parasitology · doi:10.3347/kjp.2015.53.3.265 · Cited by 36
Sirugo, G., Predazzi, I. M., Bartlett, J., Tacconelli, A., Walther, M., & Williams, S. M. (2014) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.13-0622 · Cited by 39
Shah, S. S., Rockett, K. A., Jallow, M., Sisay-Joof, F., Bojang, K., Pinder, M., Jeffreys, A. E., Craik, R., Hubbart, C., Wellems, T. E., et al. (2016) · Malaria Journal · doi:10.1186/s12936-015-1045-0 · Cited by 39
“Taken together with prior work from populations where a single variant, C202T (A-), predominates, there is compelling evidence for a direct, causal role for G6PD deficiency trait in modification of clinical malaria subphenotypes, confirming past results demonstrating protection from CM [14, 22], as well as the more re…”
BackgroundResultSelf-citationLee, J., Kim, T., Kang, J., Jun, H., Lê, H. G., Thái, T. L., Sohn, W., Myint, M. K., Lin, K., Kim, T., et al. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3031-y · Cited by 40
“It has been proposed that G6PD variants render males substantial protection against severe malaria [15].”
BackgroundSantos, S. D. S., Clark, T. G., Campino, S. G., Suárez-Mútis, M. C., Rockett, K. A., Kwiatkowski, D. P., & Fernandes, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036692 · Cited by 36
“The sickle-cell trait (HbS) [8], G6PD (reviewed in [9]), and ABO blood group [10], are amongst a number of host genes with polymorphisms found to reduce the risk of severe malaria.”
BackgroundRavenhill, B. J., Kanjee, U., Ahouidi, A. D., Nobre, L., Williamson, J. C., Goldberg, J. M., Antrobus, R., Dièye, T. N., Duraisingh, M. T., & Weekes, M. P. (2019) · Communications Biology · doi:10.1038/s42003-019-0596-y · Cited by 41
Genetic determinants of glucose-6-phosphate dehydrogenase activity in Kenya
Shah, S. S., Macharia, A., Makale, J., Uyoga, S., Kivinen, K., Craik, R., Hubbart, C., Wellems, T. E., Rockett, K. A., Kwiatkowski, D. P., et al. (2014) · BMC Medical Genetics · doi:10.1186/s12881-014-0093-6 · Cited by 26
“Association studies of severe malaria have disagreed over the strength and specificity of protection, especially with respect to gender, with past studies demonstrating protection for only males [1], only females [2], both [3,4], or neither [5].”
ResultSelf-citationThe global role of G6PD in infection and immunity
Shah, S. S., Stone, E. F., Francis, R. O., & Karafin, M. S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1393213 · Cited by 39
Santana, M. S., Lacerda, M., Barbosa, M. D. G. V., Alecrim, W. D., & Alecrim, M. D. G. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005259 · Cited by 31
Galatas, B., Mabote, L., Simone, W., Matambisso, G., Nhamússua, L., Mañú‐Pereira, M. D. M., Menéndez, C., Saúte, F., Macete, E., Bassat, Q., et al. (2017) · Malaria Journal · doi:10.1186/s12936-016-1674-y · Cited by 31
“As expected in a country with endemic malaria, G6PD deficiency prevalence estimates resemble those found in malaria endemic countries [4, 5, 24].”
ResultMéndez-Cuadro, D., Linares, M., Díez, A., Puyet, A., & Bautista, J. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.024 · Cited by 40
G6PD deficiency and malaria selection
Luzzatto, L. (2011) · Heredity · doi:10.1038/hdy.2011.90 · Cited by 29
“…on genetic protection against malaria is not easy, in part because the differences in fitness associated with individual genotypes may be small; therefore, it is probably best to consider all independent studies (for instance, in addition to those already mentioned, that by Guindo et al. (2007).”
BackgroundGueye, N. S. G., Peko, S. M., Nderu, D., Koukouikila-Koussounda, F., Vouvoungui, C., Kobawila, S. C., Velavan, T. P., & Ntoumi, F. (2019) · Malaria Journal · doi:10.1186/s12936-019-2688-z · Cited by 29
Malaria and Chinese economic activities in Africa
Cervellati, M., Esposito, E., Sunde, U., & Yuan, S. (2021) · Journal of Development Economics · doi:10.1016/j.jdeveco.2021.102739 · Cited by 31
“Finally, G6PD deficiency is a genetic disorder that provides significant protection against severe, life-threatening malaria such as cerebral malaria for male but not female children (Guindo et al., 2007).”
BackgroundOlupot‐Olupot, P., Engoru, C., Thompson, J. A., Nteziyaremye, J. G., Chebet, M., Ssenyondo, T., Dambisya, C. M., Okuuny, V., Wokulira, R., Amorut, D., et al. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-67 · Cited by 33
“Conversely, sickle cell trait (HbAS), heterozygous and homozygous α-thalassemia and G6PD deficiency were found in lower frequencies than in the background population (unpublished observations), consistent with previous observations that these traits are associated with host protection from severe malaria [21-23].”
ResultAmoako, N., Asante, K. P., Adjei, G. O., Awandare, G. A., Bimi, L., & Owusu‐Agyei, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112868 · Cited by 36
“Guindo et al. (2007) found out that partially deficient females suffer the same morbidity and mortality of Plasmodium falciparum infection as non-deficient patients [33].”
BackgroundG6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon
Dombrowski, J. G., de Souza, R. M., Curry, J. L., Hinton, L., Silva, N. R. M., Grignard, L., Gonçalves, L. A., Gomes, A. R., Epiphânio, S., DRAKELEY, C. J., et al. (2017) · Malaria Journal · doi:10.1186/s12936-017-1889-6 · Cited by 36
Tsegaye, A., Golassa, L., Mamo, H., & Erko, B. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-438 · Cited by 21
“G6PDd was associated with protection against severe malaria in males but not in heterozygous females [37].”
BackgroundLi, J., Lange, L. A., Duan, Q., Lu, Y., Singleton, A., Zonderman, A. B., Evans, M. K., Li, Y., Taylor, H. A., Willis, M. S., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu454 · Cited by 31
“This variant is also implicated in malaria resistance, and the Aform of G6PD deficiency in Africa is under strong natural selection from the preferential protection it provides to hemizygous males and homozygous females against life-threatening malaria (24).”
BackgroundAntwi-Baffour, S. S., Adjei, J. K., Forson, P., Akakpo, S., Kyeremeh, R., & Seidu, M. A. (2019) · Anemia · doi:10.1155/2019/3179173 · Cited by 28
“Furthermore, G6PD enzymatic activity between male and female is due to the fact that the phenomenon of lionization activates only one X chromosome in each female’s cell [22, 23].”
BackgroundDunyo, S., Sirugo, G., Sesay, S., Bisseye, C., Njie, F., Adiamoh, M., Nwakanma, D., Diatta, M., Janha, R., Sisay Joof, F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017371 · Cited by 25
“have reported G6PD 202 frequencies of more 10% in Malinke people (Malian Mandinka) [33] the frequency of this mutation in Gambians is considerably lower, as also confirmed by Clark et al.”
BackgroundMarked variation in prevalence of malaria-protective human genetic polymorphisms across Uganda
Walakira, A., Tukwasibwe, S., Kiggundu, M., Verra, F., Kakeeto, P., Ruhamyankaka, E., DRAKELEY, C. J., Dorsey, G., Kamya, M. R., Nsobya, S. L., et al. (2017) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2017.09.021 · Cited by 24
“4 has been associated with protection against severe malaria in African populations (Guindo et al., 2007; Ruwende et al., 1995), although associations for this polymorphism have been less consistent than for sickle hemoglobin and α-thalassemia (Verra et al.”
BackgroundGenetic evidence of tri-genealogy hypothesis on the origin of ethnic minorities in Yunnan
Yang, Z., Chen, H., Lü, Y., Gao, Y., Sun, H., Wang, J., Li, J., Chu, J., & Xu, S. (2022) · BMC Biology · doi:10.1186/s12915-022-01367-3 · Cited by 25
An evolutionary perspective of how infection drives human genome diversity: the case of malaria
Mangano, V. D., & Modiano, D. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.06.004 · Cited by 30
Fairhurst, R. M., & Wellems, T. E. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00276-9 · Cited by 31
Self-citationMoon, J., Louie, T. L., Jain, D., Sofer, T., Schurmann, C., Below, J. E., Lai, C., Avilés-Santa, L. M., Talavera, G. A., Smith, C. E., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0168 · Cited by 26
“This explains the survival advantage of G6PD deficiency against malaria because it uses RBCs asahostcell (32).”
BackgroundNguetse, C. N., Meyer, C. G., Adégnika, A. A., Agbenyega, T., Ogutu, B. R., Kremsner, P. G., & Velavan, T. P. (2016) · Malaria Journal · doi:10.1186/s12936-016-1396-1 · Cited by 27
“While meanwhile many G6PD variants have been described [8, 11], the main focus was on the most relevant three variants (376A (G6PD type B, no deficiency), 376G (moderate G6PD deficiency type A+) and 202A severe G6PD deficiency type A−) in Africa [26].”
BackgroundJeremiah, Z. A., Jeremiah, T. A., & Emelike, F. (2010) · PubMed · Cited by 28
Metadata
- Authors
- Guindo, A., Fairhurst, R. M., Doumbo, O. K., Wellems, T. E., & Diallo, D. A.
- Affiliations
- National Institutes of Health (US)
- University of Bamako (ML)
- Corresponding author
- Wellems, Thomas E
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-03-13
- Volume
- 4
- Issue
- 3
- Pages
- e66
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC1820604
- OpenAlex
- W2020310537
- Cited by
- 272
- References
- 27
- Citations by year
- 2026: 6 · 2025: 1 · 2024: 9 · 2023: 8 · 2022: 20 · 2021: 23 · 2020: 14 · 2019: 16 · 2018: 12 · 2017: 19 · 2016: 12 · 2015: 18 · 2014: 21 · 2013: 14 · 2012: 18
- FWCI
- 15.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- NHLBI Division of Intramural Research
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- glucose-6-phosphate dehydrogenase deficiency, severe malaria, Plasmodium falciparum, X-linked inheritance, hemizygous males, heterozygous females, X chromosome inactivation, malaria resistance, cerebral malaria, parasite density, natural selection
- MeSH terms
- Alleles, Child, Child, Preschool, Female, Glucosephosphate Dehydrogenase, Glucosephosphate Dehydrogenase Deficiency, Heterozygote, Humans, Immunity, Innate, Malaria, Male, Mali, Selection, Genetic, Sex Factors, Case-Control Studies, Genetic Diseases, X-Linked, Chromosomes, Human, X, Genes, X-Linked
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.